Back

Finerenone in reducing mortality and morbidity in diabetic kidney disease

30 June 2021 (09:52 - 10:02)
Organised by:
Congress Presentation Part of: Improving cardiovascular and renal outcomes in diabetic kidney disease Chronic Kidney Disease Open Access Heart Failure 2021

About the speaker

Photo
Professor Gerasimos Filippatos

National & Kapodistrian University of Athens Medical School, Athens (Greece)

3 More presentations in this session

Presentation thumbnail
Welcome and introduction.
Professor S. Anker (Berlin, DE)
Video
Presentation thumbnail
Mineralcorticoid-antagonists in chronic kidney disease and Type 2 Diabetes: Key clinical findings from current studies.
Professor R. Schmieder (Erlangen, DE)
Video
Presentation thumbnail
Discussion and closure.
Video

Access the full session

Session thumbnail
Improving cardiovascular and renal outcomes in diabetic kidney disease
Video

The Event

Event poster

Heart Failure 2021

30 June 2021 09:52 CET
You may be interested in
thumbnail
Congress Presentation
Effect of finerenone on morbidity and mortality in chronic kidney disease and type 2 diabetes: FINE-HEART analysis of 3 randomized clinical trials
19 May 2025
thumbnail
Congress Session
Guidelines in Practice: cardio-renal protection in patients with diabetes
1 September 2024
thumbnail
Congress Session
New treatments on the horizon
20 May 2025
thumbnail
Congress Session
Does aldosterone synthase inhibition hold a key to transforming cardiorenal care?
19 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources